• Health & Medicine

Leukaemia drug shows potential for rare type of ovarian cancer

A drug already approved for leukaemia patients could also be used to treat a specific type of ovarian cancer. A drug already approved for leukaemia patients could also be used to treat a specific type of ovarian cancer.

30 June 2016

• Health & Medicine

Our Moonshot pledge to accelerate research on detecting early signs of cancer

We've partnered with the Cancer Moonshot initiative, set up by US President Barack Obama in 2016 to accelerate progress against cancer. We've partnered with the Cancer Moonshot initiative, set up by US President Barack Obama in 2016 to accelerate progress against cancer.

29 June 2016

• Health & Medicine

Tailored health campaigns could help ethnic groups spot cancer symptoms earlier

Developing campaigns that are relevant to different cultures is vital to make sure more people from all ethnic groups get cancer symptoms checked out early. Developing campaigns that are relevant to different cultures is vital to make sure more people from all ethnic groups get cancer symptoms checked out early.

29 June 2016

• Health & Medicine

High-tech scans spare lymphoma patients intensive chemo

Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech scans that can predict the outcome of treatment. Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech scans that can predict the outcome of treatment.

22 June 2016

• Health & Medicine

Lab study ‘sheds new light’ on BRCA-linked breast cancer

An osteoporosis drug could help prevent breast cancers in women at risk of the disease. An osteoporosis drug could help prevent breast cancers in women at risk of the disease.

21 June 2016

• Health & Medicine

Prostate cancer trial results should mean fewer hospital trips to have radiotherapy

The results of a clinical trial testing radiotherapy doses for treating prostate cancer should be good news for men. The results of a clinical trial testing radiotherapy doses for treating prostate cancer should be good news for men.

20 June 2016

• Health & Medicine

Combination immunotherapy treatment for melanoma given NHS approval

Melanoma patients in England and Wales are to become the first in Europe to benefit from a powerful combination of immunotherapy drugs. Melanoma patients in England and Wales are to become the first in Europe to benefit from a powerful combination of immunotherapy drugs.

17 June 2016

• Health & Medicine

Less educated women less likely to spot breast cancer symptoms

Women with fewer qualifications are less likely to recognise potential breast cancer symptoms according to a Cancer Research UK-funded study in Psycho-Oncology Women with fewer qualifications are less likely to recognise potential breast cancer symptoms according to a Cancer Research UK-funded study in Psycho-Oncology

17 June 2016

• Health & Medicine

New technique could spot ‘invisible’ ovarian tumours during surgery

A new imaging technique could help spot ovarian tumours during surgery that are not visible to the naked eye. A new imaging technique could help spot ovarian tumours during surgery that are not visible to the naked eye.

16 June 2016

• Health & Medicine
• Science & Technology

ASCO 2016: will fine-tuning treatments require redefined tumours?

From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference. From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference.

15 June 2016

• Health & Medicine

Chemotherapy may boost immunotherapy power in ovarian cancer

Women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy Women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy

15 June 2016

• Health & Medicine

Middle aged more likely to be diagnosed with advanced lung cancer

Younger patients aged 50 to 64 are more likely to be diagnosed with late stage lung cancer than older patients according to new data. Younger patients aged 50 to 64 are more likely to be diagnosed with late stage lung cancer than older patients according to new data.

14 June 2016